课题基金 / 基金详情

项目摘要

项目成果

chunxiang Zhang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic wounds induced by the impaired wound healing especially in diabetic patients and aged individuals are still a major unsolved biomedical challenge. This has highlighted the importance and urgency of studying the novel mechanisms of the impaired wound healing and exploring now therapeutic options. MicroRNAs (miRNAs) have emerged as a novel class of noncoding RNAs with tremendous biological functions. The goals of this project are to determine the miRNA mechanism and therapeutics of impaired wound healing. Using RCR based array and deep-sequencing analysis as well as qRT-PCR, we identified a group of miRNAs that are aberrantly expressed in bone marrow (BM)-derived endothelial progenitor cells (EPCs) isolated from diabetic and aged individuals and mice. Among them, let-7 family members, let-7b, let-7c, let-7d, and let-7d* are significantly increased. The hypothesis of this proposal is that Let-7 family members play important roles in the impaired cellular functions of EPCs and impaired wound healing in diabetes and aged individuals via their target genes. miRNA-reprogrammed "smart" EPCs via modulators of let-7 family may represent a novel effective therapy for chronic wounds. We will test our hypothesis via three specific aims: Aim 1 will determine the effects of let-7 family members on the migration, proliferation and apoptosis of EPCs in vitro. Aim 2 will determine the effects of let-7-reprogrammed autologous EPCs on wound angiogenesis and wound healing in diabetic and aged mice in vivo. Aim 3 will determine the molecular mechanisms of let-7-mediated biological effects. The biological role of let-7 family on refractory wounds via gene reprogramming in EPCs is an unexplored research field. The proposed study will utilize the latest cellular, molecular, and whole animal approaches to target the major unsolved biomedical challenge: chronic wounds. Uncovering the novel molecular mechanisms and therapeutics of the impaired wound healing at translational level via miRNAs may open a new scientific paradigm in chronic wounds.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/wrr.12310
发表时间: 2015-07
期刊: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
影响因子: --
作者: [Goldufsky J, Wood SJ, Jayaraman V, Majdobeh O, Chen L, Qin S, Zhang C, DiPietro LA, Shafikhani SH]
通讯作者: Shafikhani SH
Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response.
促炎趋化因子 CCL2 (MCP-1) 通过恢复巨噬细胞反应来促进糖尿病伤口的愈合。
DOI: 10.1371/journal.pone.0091574
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Wood S, Jayaraman V, Huelsmann EJ, Bonish B, Burgad D, Sivaramakrishnan G, Qin S, DiPietro LA, Zloza A, Zhang C, Shafikhani SH]
通讯作者: Shafikhani SH
GOLPH3 in vascular smooth muscle cell biology and vascular disease
MicroRNA mechanism and therapeutics of impaired wound healing
  • 批准号:
    8413586
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2012
  • 负责人:
    chunxiang Zhang
  • 依托单位:
Circulating cell-free microRNAs in atherogenesis
  • 批准号:
    8299869
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2012
  • 负责人:
    chunxiang Zhang
  • 依托单位:
Circulating cell-free microRNAs in atherogenesis
  • 批准号:
    8442296
  • 项目类别:
  • 资助金额:
    $21.85万
  • 财政年份:
    2012
  • 负责人:
    chunxiang Zhang
  • 依托单位:
海外基金